Ronsheim Matthew
Insider CIK 1824386 · INVA See Remarks · ETTX See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INVA Innoviva, Inc. | F Tax w/h | 2024-05-20 | 2024-05-21 | 268 | $16.13 | $4.3K | 40,510 | SEC↗ |
| INVA Innoviva, Inc. | A Award deriv | 2024-03-05 | 2024-03-07 | 27,338 | — | $0 | 120,438 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2024-03-05 | 2024-03-07 | 12,768 | $14.88 | $190.0K | 40,778 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2024-02-20 | 2024-02-22 | 807 | $15.80 | $12.8K | 28,010 | SEC↗ |
| INVA Innoviva, Inc. | A Award deriv | 2024-01-18 | 2024-01-22 | 60,000 | — | $0 | 93,100 | SEC↗ |
| INVA Innoviva, Inc. | F Tax w/h | 2024-01-18 | 2024-01-22 | 1,600 | $16.05 | $25.7K | 28,817 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 20,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 33,333 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 15,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 20,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer | 2022-07-11 | 2022-07-11 | 150,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | U Tender | 2022-07-07 | 2022-07-11 | 17,572 | $2.20 | $38.7K | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2022-01-18 | 2022-01-19 | 125,000 | — | $0 | 167,572 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | F Tax w/h | 2021-11-02 | 2021-11-03 | 3,669 | $2.94 | $10.8K | 42,572 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2021-10-19 | 2021-10-20 | 25,000 | — | $0 | 50,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | S Sale | 2021-10-19 | 2021-10-20 | 3,759 | $3.19 | $12.0K | 46,241 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 33,333 | — | $0 | 33,333 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 40,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2021-01-15 | 2021-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |